BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9514179)

  • 1. Right-shifting the oxyhemoglobin dissociation curve with RSR13: effects on high-energy phosphates and myocardial recovery after low-flow ischemia.
    Woods JA; Storey CJ; Babcock EE; Malloy CR
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):359-63. PubMed ID: 9514179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a pharmacologically-induced shift of hemoglobin-oxygen dissociation on myocardial energetics during ischemia in patients with coronary artery disease.
    Najjar SS; Bottomley PA; Schulman SP; Waldron MM; Steffen RP; Gerstenblith G; Weiss RG
    J Cardiovasc Magn Reson; 2005; 7(4):657-66. PubMed ID: 16136855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preservation of canine myocardial high-energy phosphates during low-flow ischemia with modification of hemoglobin-oxygen affinity.
    Weiss RG; Mejia MA; Kass DA; DiPaula AF; Becker LC; Gerstenblith G; Chacko VP
    J Clin Invest; 1999 Mar; 103(5):739-46. PubMed ID: 10074492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RSR13, a synthetic allosteric modifier of hemoglobin, improves myocardial recovery following hypothermic cardiopulmonary bypass.
    Kilgore KS; Shwartz CF; Gallagher MA; Steffen RP; Mosca RS; Bolling SF
    Circulation; 1999 Nov; 100(19 Suppl):II351-6. PubMed ID: 10567328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RSR13, a synthetic modifier of hemoglobin-oxygen affinity, enhances the recovery of stunned myocardium in anesthetized dogs.
    Pagel PS; Hettrick DA; Montgomery MW; Kersten JR; Steffen RP; Warltier DC
    J Pharmacol Exp Ther; 1998 Apr; 285(1):1-8. PubMed ID: 9535987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of RSR13, a synthetic allosteric modifier of hemoglobin, alone and in combination with dizocilpine, on outcome from transient focal cerebral ischemia in the rat.
    Sarraf-Yazdi S; Sheng H; Grocott HP; Bart RD; Pearlstein RD; Steffen RP; Warner DS
    Brain Res; 1999 May; 826(2):172-80. PubMed ID: 10224294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of enhanced oxygen release from hemoglobin by RSR13 in an acute renal failure model.
    Burke TJ; Malhotra D; Shapiro JI
    Kidney Int; 2001 Oct; 60(4):1407-14. PubMed ID: 11576354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing hemoglobin oxygen affinity does not increase hydroxyl radicals after acute subdural hematoma in the rat.
    Doppenberg EM; Rice MR; Alessandri B; Qian Y; Di X; Bullock R
    J Neurotrauma; 1999 Feb; 16(2):123-33. PubMed ID: 10098957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a synthetic allosteric modifier of hemoglobin oxygen affinity on outcome from global cerebral ischemia in the rat.
    Grocott HP; Bart RD; Sheng H; Miura Y; Steffen R; Pearlstein RD; Warner DS
    Stroke; 1998 Aug; 29(8):1650-5. PubMed ID: 9707208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting functional recovery from ischemia in the rat myocardium.
    Jeffrey FM; Storey CJ; Malloy CR
    Basic Res Cardiol; 1992; 87(6):548-58. PubMed ID: 1485887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dose-dependent effect of RSR13, a synthetic allosteric modifier of hemoglobin, on physiological parameters and brain tissue oxygenation in rats.
    Grinberg OY; Miyake M; Hou H; Steffen RP; Swartz HM
    Adv Exp Med Biol; 2003; 530():287-96. PubMed ID: 14562725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of RSR13 on microvascular Po
    Watanabe A; Poole DC; Kano Y
    J Appl Physiol (1985); 2017 Oct; 123(4):764-772. PubMed ID: 28620055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of RSR13, a synthetic allosteric modifier of hemoglobin, on brain tissue pO2 (measured by EPR oximetry) following severe hemorrhagic shock in rats.
    Miyake M; Grinberg OY; Hou H; Steffen RP; Elkadi H; Swartz HM
    Adv Exp Med Biol; 2003; 530():319-29. PubMed ID: 14562728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR measurements of Na+ and cellular energy in ischemic rat heart: role of Na(+)-H+ exchange.
    Pike MM; Luo CS; Clark MD; Kirk KA; Kitakaze M; Madden MC; Cragoe EJ; Pohost GM
    Am J Physiol; 1993 Dec; 265(6 Pt 2):H2017-26. PubMed ID: 8285240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of the specific endothelin-1 antagonist BQ610 on mechanical function and energy metabolism during ischemia/reperfusion injury in isolated perfused rat hearts.
    Illing B; Horn M; Han H; Hahn S; Bureik P; Ertl G; Neubauer S
    J Cardiovasc Pharmacol; 1996 Apr; 27(4):487-94. PubMed ID: 8847864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-ischemic RSR13 amplifies the effect of dizocilpine on outcome from transient focal cerebral ischemia in the rat.
    Mackensen GB; Nellgård B; Sarraf-Yazdi S; Dexter F; Steffen RP; Grocott HP; Warner DS
    Brain Res; 2000 Jan; 853(1):15-21. PubMed ID: 10627303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular adenosine levels and cellular energy metabolism in ischemically preconditioned rat heart.
    Harrison GJ; Willis RJ; Headrick JP
    Cardiovasc Res; 1998 Oct; 40(1):74-87. PubMed ID: 9876319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of FI(O(2)) on hemodynamic responses and O(2) transport during RSR13-induced reduction in P(50).
    Eichelbrönner O; Sielenkämper A; D'Almeida M; Ellis CG; Sibbald WJ; Chin-Yee IH
    Am J Physiol; 1999 Jul; 277(1):H290-8. PubMed ID: 10409208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of metabolic inhibition and cellular pH in mediating preconditioning contractile and metabolic effects in rat hearts.
    de Albuquerque CP; Gerstenblith G; Weiss RG
    Circ Res; 1994 Jan; 74(1):139-50. PubMed ID: 8261587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of low-flow ischemia on K+ fluxes in isolated rat hearts assessed by 87Rb NMR.
    Kupriyanov VV; Xiang B; Kuzio B; Deslauriers R
    J Mol Cell Cardiol; 1999 Apr; 31(4):817-26. PubMed ID: 10329209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.